SMTL ID : 5kzc.2 (2 other biounits)

Crystal structure of an HIV-1 gp120 engineered outer domain with a Man9 glycan at position N276, in complex with broadly neutralizing antibody VRC01

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.25 Å
Oligo State
hetero-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Jardine, J.G. et al., Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. Plos Pathog. (2016)
Release Date
2016-08-10
Peptides
VRC01 Fab heavy chain: A
Engineered outer domain of gp120: B
VRC01 Fab light chain: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B
B
C
C
D

VRC01 Fab heavy chain

Engineered outer domain of gp120

VRC01 Fab light chain

Related Entries With Identical Sequence

3ngb.1 | 3ngb.2 | 3ngb.3 | 3ngb.4 | 4lss.1 | 4lst.1 | 5kzc.1 | 5kzc.3